PeptiMed, Inc.
Records under this name other than the patents PeptiMed, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 3 of 3 · Back to PeptiMed, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,680,045 | Compositions of a peptide targeting system for treating cancer Lapsed on the fee record Ended Mar 25, 2026 · USPTO record | Lapsed on the fee record | Ended Mar 25, 2026 | USPTO record |
| US 10,111,898 | Anti-tumor compositions and methods Lapsed on the fee record Ended Oct 30, 2022 · USPTO record | Lapsed on the fee record | Ended Oct 30, 2022 | USPTO record |
| US 5,885,956 | Treatment for diabetes using a gastrin/CCK receptor ligand and an EGF receptor ligand Formerly held Term ended Term ended no later than Mar 23, 2019 · Low confidence | Term ended | Term ended no later than Mar 23, 2019 | Low confidence |